The clinical significance of the multidrug resistance proteins expression in patients with acute myeloid leukemia.

被引：1
|
作者：
Podolak-Dawidziak, M
Dus, D
Kielbinski, M
Paprocka, M
Kuliszkowicz-Janus, M
Kuliczkowski, K
机构：
[1] Med Univ, Dept Haematol, Wroclaw, Low Silesia, Poland
[2] Polish Acad Sci, Inst Immunol & Expt Therapy, Wroclaw, Low Silesia, Poland
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.4411.4411
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4411
引用
收藏
页码：186B / 186B
页数：1
相关论文
共 50 条
  • [1] Prognostic significance of multidrug resistance proteins expression in acute myeloid leukemia.
    Zakharov, Oleg D.
    Rybalkina, Ekaterina U.
    Stavrovskaya, Alla A.
    Volkova, Maya
    BLOOD, 2006, 108 (11) : 168B - 168B
  • [2] Clinical significance of MYC expression in acute myeloid leukemia.
    Ohanian, Maro
    Kantarjian, Hagop M.
    Rozovski, Uri
    Loghavi, Sanam
    Huh, Yang
    Abruzzo, Lynne
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    Stingo, Franceso
    Hu, Peter
    Nguyen, Martin H.
    Fox, Patricia S.
    Medeiros, L. Jeffrey
    Estrov, Zeev
    Bueso-Ramos, Carlos E.
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Individualized Multidrug Resistance In Acute Myeloid Leukemia.
    Patel, Chirayu
    Gillet, Jean-Pierre
    Stenke, Leif
    Lindberg, Marita
    Bjorkholm, Magnus
    Sjoberg, Jan
    Viktorsson, Kristina
    Lewensohn, Rolf
    Landgren, Ola
    Gottesman, Michael M.
    BLOOD, 2010, 116 (21) : 1033 - 1033
  • [4] PROGNOSTIC SIGNIFICANCE OF THE MULTIDRUG RESISTANCE PROTEINS CO-EXPRESSION IN ACUTE MYELOID LEUKEMIA
    Zakharov, O. D.
    Rybalkina, E. Yu
    Stavrovskaya, A. A.
    Volkova, M. A.
    Lunin, V. A.
    Zhukov, N. V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 481 - 481
  • [5] Clinical significance of molecular findings in acute myeloid leukemia.
    Bloomfield, Clara D.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [6] The expression of multidrug resistance-associated protein and clinical signification in acute leukemia.
    Xie, ZX
    Zhu, PA
    BLOOD, 1998, 92 (10) : 198B - 198B
  • [7] EXPRESSION AND CLINICAL SIGNIFICANCE OF MULTIDRUG RESISTANCE GENE AND MULTIDRUG RESISTANCE-ASSOCIATEDPROTEIN GENE IN ACUTE LEUKEMIA
    赖永榕
    马劼
    卢玉英
    牛威林
    向直富
    Chinese Journal of Cancer Research, 1999, (03) : 3 - 5
  • [8] Prognostic significance of VEGF receptor I and II expression in patients with acute myeloid leukemia.
    Patel, SA
    Yang, J
    Kashef, G
    Kojouri, K
    Hashmi, M
    Selby, GB
    Ozer, H
    Kamble, R
    Kharfan-Dabaja, MA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 865S - 865S
  • [9] Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group Study
    Leith, CP
    Kopecky, KJ
    Chen, IM
    Eijdems, L
    Slovak, ML
    McConnell, TS
    Head, DR
    Weick, J
    Grever, MR
    Appelbaum, FR
    Willman, CL
    BLOOD, 1999, 94 (03) : 1086 - 1099
  • [10] Clinical relevance of multidrug resistance proteins expression in patients with de novo acute myeloid leukaemia.
    Podolak-Dawidziak, Maria
    Dus, Danuta
    Kielbinski, Marek
    Paprocka, Maria
    Haus, Olga
    Kuliszkiewicz-Janus, Malgorzata
    Kuliczkowski, Kazimierz
    Frydecka, Irena
    BLOOD, 2006, 108 (11) : 169B - 169B
12345